[1]
W. Rogowski and P. Będkowski, “Prolongation of survival time and improvement of the quality of life after treatment with irinotecan liposomal in the patient with metastatic pancreatic adenocarcinoma”, OncoReview, vol. 11, no. 3(43), pp. 77-79, Jul. 2021.